p38 mitogen-activated protein kinase mediates hyperosmolarity-induced vasoconstriction through myosin light chain phosphorylation and actin polymerization in rat aorta.

Hyperosmotic stress induces the contractile response of vascular smooth muscle cells (VSMCs). Previous studies have demonstrated that cytoskeleton reorganization and Rho/Rho-kinase-mediated inactivation of myosin light chain phosphatase (MLCP) play an important role in hyperosmotic vasoconstriction, but the precise mechanism is unknown. This study aimed to investigate the contractile response of endothelium-denuded rings of rat aortas to hyperosmolar sucrose (160 mM) in the presence or absence of inhibitors for various protein kinases. We found that the hyperosmotic constriction of aortic rings was attenuated not only by ML-7 or hydroxyfasudil, specific inhibitor for myosin light chain kinase (MLCK) or Rho-kinase, respectively, but also by SB203580, a specific inhibitor for p38 mitogen-activated kinase (p38 MAPK). Hyperosmolar sucrose evoked a transient increase in cytosolic free Ca(2+) in rat VSMCs, and this response was not affected by SB203580. Western blot analysis of proteins extracted from rings showed that the hyperosmolar sucrose stimulated phosphorylation of the Rho-kinase-mediated myosin phosphatase target subunit 1, myosin light chain (MLC), and p38 MAPK. The experiments performed using a combination of the kinase inhibitors showed that hyperosmolarity-induced MLC phosphorylation is partially mediated via the SB203580-sensitive pathway and is independent of both MLCK and Rho-kinase-mediated inactivation of MLCP. Furthermore, the hyperosmolarity-induced increase in the F-actin/G-actin ratio in rings was attenuated not only by hydroxyfasudil but also by SB203580. These results suggest that p38 MAPK is involved in hyperosmotic vasoconstriction via stimulation of MLC phosphorylation and cytoskeleton reorganization through pathways independent of activation of MLCK and/or Rho-kinase-mediated mechanisms.

[1]  H. Onoe,et al.  Na+/H+ exchanger inhibitor augments hyperosmolarity-induced vasoconstriction by enhancing actin polymerization. , 2013, Vascular pharmacology.

[2]  A. Kurt,et al.  Hyperosmolar glucose induces vasoconstriction through Rho/Rho‐kinase pathway in the rat aorta , 2013, Fundamental & clinical pharmacology.

[3]  H. Okamoto,et al.  Na(+)/H(+) exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca2(+) mobilization. , 2013, Vascular pharmacology.

[4]  M. Okada,et al.  Death-Associated Protein Kinase 3 Mediates Vascular Inflammation and Development of Hypertension in Spontaneously Hypertensive Rats , 2012, Hypertension.

[5]  Francesc Posas,et al.  Response to Hyperosmotic Stress , 2012, Genetics.

[6]  C. Brocker,et al.  The role of hyperosmotic stress in inflammation and disease , 2012, Biomolecular concepts.

[7]  F. Lang,et al.  p38 MAPK Activation and Function following Osmotic Shock of Erythrocytes , 2011, Cellular Physiology and Biochemistry.

[8]  Su-Lin Lee,et al.  Identification and characterization of a novel integrin-linked kinase inhibitor. , 2011, Journal of medicinal chemistry.

[9]  W. Dai,et al.  Hyperosmotic stress-induced corneal epithelial cell death through activation of Polo-like kinase 3 and c-Jun. , 2011, Investigative ophthalmology & visual science.

[10]  Chris K C Wong,et al.  Regulatory function of hyperosmotic stress-induced signaling cascades in the expression of transcription factors and osmolyte transporters in freshwater Japanese eel primary gill cell culture , 2011, Journal of Experimental Biology.

[11]  L. Hodgson,et al.  Dynamics of the Rho-family small GTPases in actin regulation and motility , 2011, Cell adhesion & migration.

[12]  J. Vicencio,et al.  Parallel activation of Ca2+-induced survival and death pathways in cardiomyocytes by sorbitol-induced hyperosmotic stress , 2010, Apoptosis.

[13]  C. Waters,et al.  Angiotensin II-Induced Migration of Vascular Smooth Muscle Cells Is Mediated by p38 Mitogen-Activated Protein Kinase-Activated c-Src through Spleen Tyrosine Kinase and Epidermal Growth Factor Receptor Transactivation , 2010, Journal of Pharmacology and Experimental Therapeutics.

[14]  Kazuhiro Ishida,et al.  Identification of death-associated protein kinases inhibitors using structure-based virtual screening. , 2009, Journal of medicinal chemistry.

[15]  Zhenqi Liu,et al.  p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus. , 2009, Endocrine, metabolic & immune disorders drug targets.

[16]  K. Morgan,et al.  Smooth muscle signalling pathways in health and disease , 2008, Journal of cellular and molecular medicine.

[17]  S. Gunst,et al.  Cytoskeletal remodeling in differentiated vascular smooth muscle is actin isoform dependent and stimulus dependent. , 2008, American journal of physiology. Cell physiology.

[18]  S. Gunst,et al.  Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. , 2008, American journal of physiology. Cell physiology.

[19]  A. Altman,et al.  PKCδ Acts Upstream of SPAK in the Activation of NKCC1 by Hyperosmotic Stress in Human Airway Epithelial Cells* , 2008, Journal of Biological Chemistry.

[20]  S. Orlov,et al.  Vascular Smooth Muscle Contraction Evoked by Cell Volume Modulation: Role of the Cytoskeleton Network , 2008, Cellular Physiology and Biochemistry.

[21]  A. C. Thirone,et al.  Hyperosmotic stress induces Rho‐Rho kinase‐LIM kinase‐mediated cofilin phosphorylation , 2007, American journal of physiology. Cell physiology.

[22]  H. Kim,et al.  JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells , 2006 .

[23]  K. Murthy.  Signaling for contraction and relaxation in smooth muscle of the gut. , 2006, Annual review of physiology.

[24]  G. Stoner.  Hyperosmolar hyperglycemic state. , 2005, American family physician.

[25]  O. Rotstein,et al.  Is myosin light-chain phosphorylation a regulatory signal for the osmotic activation of the Na+-K+-2Cl- cotransporter? , 2005, American journal of physiology. Cell physiology.

[26]  M. Gustin,et al.  MAP kinases and the adaptive response to hypertonicity: functional preservation from yeast to mammals. , 2004, American journal of physiology. Renal physiology.

[27]  A. Kilin,et al.  Cell-volume-dependent vascular smooth muscle contraction: role of Na+, K+, 2Cl− cotransport, intracellular Cl− and L-type Ca2+ channels , 2004, Pflügers Archiv.

[28]  M. Shimizu,et al.  Activation of Ca2+/calmodulin‐dependent protein kinase II is involved in hyperosmotic induction of the human taurine transporter , 2004, FEBS letters.

[29]  M. Dell'Acqua,et al.  Rac–MEKK3–MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock , 2003, Nature Cell Biology.

[30]  A. Criollo,et al.  Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis , 2003, Journal of Biological Chemistry.

[31]  W. Arthur,et al.  Hyperosmotic stress activates Rho: differential involvement in Rho kinase-dependent MLC phosphorylation and NKCC activation. , 2003, American journal of physiology. Cell physiology.

[32]  G. Gabbiani,et al.  Regulatory volume increase is associated with p38 kinase-dependent actin cytoskeleton remodeling in rat kidney MTAL. , 2003, American journal of physiology. Renal physiology.

[33]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[34]  E. White,et al.  Effects of hyperosmotic shrinking on ventricular myocyte shortening and intracellular Ca2+ in streptozotocin-induced diabetic rats , 2002, Pflügers Archiv.

[35]  D. Min,et al.  The p38 mitogen-activated protein kinase is involved in stress-induced phospholipase D activation in vascular smooth muscle cells , 2002, Experimental & Molecular Medicine.

[36]  C. Sutherland,et al.  Ca2+-independent Smooth Muscle Contraction , 2001, The Journal of Biological Chemistry.

[37]  A. Lazou,et al.  Activation of multiple MAPK pathways (ERKs, JNKs, p38‐MAPK) by diverse stimuli in the amphibian heart , 2001, Molecular and Cellular Biochemistry.

[38]  I. Doull,et al.  Osmotically induced cytosolic free Ca(2+) changes in human neutrophils. , 2001, Biochimica et biophysica acta.

[39]  N. Sakai,et al.  p38 MAP kinase is required for vasopressin-stimulated HSP27 induction in aortic smooth muscle cells. , 2000, Hypertension.

[40]  A. Takeshita,et al.  Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. , 1999, Cardiovascular research.

[41]  F. Suizu,et al.  ZIP kinase identified as a novel myosin regulatory light chain kinase in HeLa cells , 1999, FEBS letters.

[42]  G. King,et al.  Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. , 1999, The Journal of clinical investigation.

[43]  H. Okamoto,et al.  Kininogen expression by rat vascular smooth muscle cells: stimulation by lipopolysaccharide and angiotensin II. , 1998, Biochimica et biophysica acta.

[44]  S. Orlov,et al.  Bumetanide-sensitive Ion Fluxes in Vascular Smooth Muscle Cells: Lack of Functional Na+, K+, 2 Cl− Cotransport , 1996, The Journal of Membrane Biology.

[45]  S. Orlov,et al.  Cell volume in vascular smooth muscle is regulated by bumetanide-sensitive ion transport. , 1996, The American journal of physiology.

[46]  S. Hadjiyannakis,et al.  Hyperglycemic hyperosmolar syndrome at the onset of type 2 diabetes mellitus in an adolescent male. , 2012, Paediatrics & child health.

[47]  K. Won,et al.  p38 mitogen-activated protein kinase contributes to angiotensin II-stimulated migration of rat aortic smooth muscle cells. , 2007, Journal of pharmacological sciences.

[48]  Bokyung Kim,et al.  p38 Mitogen-activated protein kinase regulates vasoconstriction in spontaneously hypertensive rats. , 2004, Journal of pharmacological sciences.

[49]  S. Hirai,et al.  Hyperosmolality induces activation of cPKC and nPKC, a requirement for ERK1/2 activation in NIH/3T3 cells. , 2000, American journal of physiology. Cell physiology.